Showing 861-870 of 20379 results for "".
Closing the Gap to Care: Assessing CAD and Improving Patient Outcomes with Revascularization
https://reachmd.com/programs/cme/closing-the-gap-to-care-assessing-cad-and-improving-patient-outcomes-with-revascularization/14855/Are we really doing our best to assess CAD in our patients? Experts discuss ways to close gaps in care and improve patient outcomes.Immunotherapy for Management of Refractory and Super-Refractory Status Epilepticus
https://reachmd.com/diseases-diagnoses/epilepsy-seizures/immunotherapy-for-management-of-refractory-and-super-refractory-status-epilepticus/39948/This review explores the role of neuroinflammation in refractory and super-refractory status epilepticus, as well as the role of therapeutic immunomodulation in their management.Dr. Dean Ornish, President of the Preventive Medicine Research Institute
https://reachmd.com/programs/conversations-on-health-care/dr-dean-ornish-president-preventive-medicine-research-institute/7939/This week, hosts Mark Masselli and Margaret Flinter speak with Dr. Dean Ornish, Founder and President of the Preventive Medicine Research Institute. He analyzes the new USDA nutritional guidelines and discusses the mounting empirical evidence linking sound nutrition and integrative medicine to the pOn the Frontline: Empowering IO Therapies for Patients with HER2-Negative G/GEJC
https://reachmd.com/programs/project-oncology/io-therapies-for-patients-with-her2-negative-ggejc/35513/For patients who are diagnosed with metastatic gastric cancer, the five-year overall survival rate is roughly seven percent, underscoring the need for additional treatment options.1 Fortunately, there has been advancement in gastric cancer care, including the FDA approval of tislelizumab plus platinNon-Stimulant Options for ADHD Patients
https://reachmd.com/programs/focus-on-neurology-and-psychiatry/non-stimulant-options-for-adhd-patients/4383/Although stimulant medications are often used to treat ADHD patients, there are patients for whom non-stimulants might also be a viable option. What are the advantages to each type of medication? Dr. Richard Rubin, clinical associate professor at the University of Vermont College of Medicine and adjThe Genetics of Migraine: Advancing Diagnosis and Personalizing Treatment
https://reachmd.com/programs/frontlines-migraine/the-genetics-of-migraine-advancing-diagnosis-and-personalizing-treatment/36156/Decades of research have transformed our understanding of migraine genetics, from rare monogenic types to complex polygenic forms. Mr. Ryan Quigley is joined by Dr. Lyn Griffiths to explore polygenic risk scores, emerging diagnostic tools, and the promise of personalized medicine in migraineEpilepsy Essentials: Novel Interictal Biomarkers for Delineating the Epileptogenic Zone in Children With Drug-Resistant Epilepsy
https://reachmd.com/programs/practical-neurology-focus-on-epilepsy-seizures/epilepsy-essentials-novel-interictal-biomarkers-for-delineating-the-epileptogenic-zone-in-children-with-drug-resistant-epilepsy/32147/Novel interictal biomarkers of epilepsy are able to identify the epileptogenic zone with precision and predict surgical outcome in children with drug-resistant epilepsy.A Resurgence of Stents
https://reachmd.com/programs/diabetes-discourse/a-resurgence-of-stents/4693/Diabetes is strongly linked with a number of risk factors for coronary problems such as high blood pressure, high cholesterol, abdominal obesity that significantly increases the risk of heart attack and stroke. Recent studies indicate that new drug-eluting stents are a reasonable option for the diabSelecting the Right Neuromodulator
https://reachmd.com/ma-issues-index/march-april-2026-issue/selecting-the-right-neuromodulator/56635/Subtle differences in botulinum toxin formulations and technique shape individualized aesthetic outcomesParticle Number Testing in the Prevention of Atherosclerosis
https://reachmd.com/programs/lipid-luminations/particle-number-testing-in-the-prevention-of-atherosclerosis/5189/What is the role of advanced lipid testing, and particle number testing in particular? How might this information change the way you treat your patients? Host Dr. Alan Brown talks with Dr. Tara Dall, medical director of Advanced Lipidology Early Detection Center for Heart Disease and Diabetes in Del